Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis

J Clin Gastroenterol. 2015 Oct;49(9):794-5. doi: 10.1097/MCG.0000000000000398.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Dose-Response Relationship, Drug
  • Humans
  • Naltrexone / administration & dosage
  • Naltrexone / adverse effects
  • Naltrexone / therapeutic use*
  • Narcotic Antagonists / administration & dosage
  • Narcotic Antagonists / adverse effects
  • Narcotic Antagonists / therapeutic use*
  • Panniculitis, Peritoneal / drug therapy*
  • Panniculitis, Peritoneal / physiopathology
  • Pilot Projects
  • Treatment Outcome

Substances

  • Narcotic Antagonists
  • Naltrexone